<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_San_Andres_Modeling skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:San Andres/Modeling</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>&lt;endnote&gt;&lt;head&gt;&lt;title&gt;&lt;endnote&gt;&lt;head&gt;&lt;meta&gt;&lt;title&gt;</TITLE><TITLE>wiki</TITLE><TITLE>wiki</TITLE><TITLE>exp</TITLE><TITLE>wiki</TITLE><TITLE>wiki</TITLE><TITLE>wiki 2</TITLE> <TABLE style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-15ao"><TBODY><TR heigth="75px"><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres" style="color: rgb(0, 0, 0);">Home </A></TD><TD style="border: 3px solid black;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Team" style="color: rgb(0, 0, 0);"> Team</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Description" style="color: rgb(0, 0, 0);"> Project</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Parts" style="color: rgb(0, 0, 0);"> Parts</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Modeling" style="color: rgb(0, 0, 0);"> Modeling</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Results" style="color: rgb(0, 0, 0);"> Results</A></TD></TR></TBODY></TABLE><TABLE style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-10nh"><TBODY><TR heigth="75px"><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Notebook" style="color: rgb(0, 0, 0);">Notebook</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Practices" style="color: rgb(0, 0, 0);"> Human Practices</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Design" style="color: rgb(0, 0, 0);"> Future Projections</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Attributions" style="color: rgb(0, 0, 0);"> Attributions</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Collaborations" style="color: rgb(0, 0, 0);"> Collaborations</A></TD></TR></TBODY></TABLE></P><DIV class="gwd-div-7xzo gwd-a-1thu"><H1 style="font-family: Algerian; font-weight: normal;"><BIG>Enzymes</BIG></H1><DIV style="text-align: justify; font-family: Cambria;"><BIG>During
our
investigation we sought the perfect enzyme to
degrade the gluten, and we found:</BIG></DIV><UL style="font-family: Cambria;"><LI><DIV style="text-align: justify;"><BIG>Prolyl
Endopeptidase: <SPAN style="" lang="EN-US">The
prolyl
endopeptidase (PEP), is a class of serine-protease able to break
peptide bonds
following a PROLINE residue terminal carboxyl group. Were studying it
its use
as a therapeutic agent against celiac disease (CD), characterized by
atrophy of
the intestinal villi and inflammation. These reactions are attributed
to
peptides rich in PROLINE that are generated during the digestion of
gluten of
some cereals. This enzyme could be used as a nutritional supplement for
individuals who suffer from celiac disease or during the processing of
starches
produced from cereals containing gluten. While it was a candidate for a
possible treatment failed to meet expectations, because its activity is
to a
high pH, which is not suitable for an average digestive. Another reason
was
that degrades the gluten slowly, which would have resulted in a longer
and
inefficient treatment.</SPAN><BIG> </BIG></BIG></DIV></LI></UL><DIV style="text-align: center; font-family: Cambria;"><DIV style="text-align: left;"><UL><LI><DIV style="text-align: justify;"><BIG>Kumamolisin
As: It is the first known example of
a collagenase derived from the family of the sedolisin. This operates
at high temperatures and low pH levels. Its characteristics, together
with those predicted are measured by comparison between a collagenase
and a peptidase from serine, which are related to the enzyme
preference, to thus Digest collagen as gluten.</BIG></DIV></LI></UL><DIV style="text-align: center;"><UL style="text-align: justify;"><LI><BIG>KumaMax (G319S, D358G, D368H, N281D): It is a
mutation of the Kumamolisin As, which is designed to digest way more
efficient gluten, because that can work at pH levels much more lower
than the original enzyme (a pH of 4.0) which is excellent for the
average digestive system. <SPAN class="hps">It was
created by the team IGEM <A href="https://2011.igem.org/Team:Washington/Celiacs/Background">Washington
2011</A></SPAN>. Other advantages
are:</BIG></LI></UL><OL style="text-align: left;"><LI style="text-align: justify;"><BIG>It is
resistant to high temperatures and acidity
of the stomach.</BIG></LI><LI style="text-align: justify;"><BIG>It is heat
stable, in others words, it is
resistant to all changes in their physical and chemical structure.</BIG></LI><LI><DIV style="text-align: justify;"><BIG>It is
easily repairable and creable.</BIG></DIV></LI></OL><DIV style="text-align: center;">   <H1 style="border-bottom: 1px solid rgb(170, 170, 170); margin: 0px 0px 0.6em; background: transparent none repeat scroll 0% 50%; -moz-background-clip: initial; -moz-background-origin: initial; -moz-background-inline-policy: initial; color: rgb(0, 0, 0); font-weight: normal; padding-top: 0.5em; padding-bottom: 0.17em; font-size: 23.876px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: 19.05px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px;"><BIG style="font-family: Algerian;">Methodology</BIG> </H1><DIV style="text-align: left;"><DIV style="text-align: justify;"><BIG style="color: rgb(0, 0, 0); font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 19.05px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px;">The
methodology consists of:</BIG></DIV><P style="text-align: justify;" class="MsoNormal"><BIG><SPAN style="" lang="EN-US">- For our
Plasmid construction, we decided to take the method standard of
Assembly
biobrick, based on grafts and vectors, front and reverse.</SPAN></BIG></P><P style="text-align: justify;" class="MsoNormal"><BIG><SPAN style="" lang="EN-US">- Then we
cut the two genes and making them again an insert front, which we took
to the
vector of the terminator making as well as the genes a front vector.</SPAN></BIG></P><P style="text-align: justify;" class="MsoNormal"><BIG><SPAN style="" lang="EN-US">- After
making two front inserts, we proceed to start with two reverse inserts
for
where we cut the three genes (Kumamax, RFP, terminator) and we make
them a
reverse insert, and we took him to the inverse vector of the RBS.</SPAN></BIG></P><P style="text-align: justify;" class="MsoNormal"><SPAN style="" lang="EN-US"><BIG>-
Finally
we proceed to cut the four genes (RBS, Kumamax, RFP, terminator) as
insert
reverse, to take them to the inverse vector of the promoter, and we
finished
building our final plasmid, the &quot;Kumamax Plux&quot;.</BIG></SPAN></P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>